ACBT With Incentive Spirometry Versus High-Frequency Chest Wall Oscillation After Thoracic Surgery (NCT07619716) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
ACBT With Incentive Spirometry Versus High-Frequency Chest Wall Oscillation After Thoracic Surgery
Pakistan42 participantsStarted 2026-06
Plain-language summary
This randomized clinical trial aims to compare the effectiveness of Active Cycle of Breathing Techniques combined with Incentive Spirometry (ACBT + IS) versus High-Frequency Chest Wall Oscillation (HFCWO) in patients undergoing thoracic surgery. Postoperative pulmonary complications such as reduced lung function, ineffective cough, and sputum retention are common after thoracic procedures and can delay recovery. A total of 42 participants will be randomly allocated into two groups: one receiving ACBT with Incentive Spirometry and the other receiving HFCWO, along with standard postoperative care. Outcomes including cough effectiveness, sputum clearance, pulmonary function tests, and patient satisfaction will be assessed at baseline, postoperative day 3, and day 5. The study aims to determine the more effective airway clearance technique to improve respiratory outcomes and enhance patient recovery following thoracic surgery.
Who can participate
Age range
18 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18-40 years
* Patients scheduled for elective thoracic surgery (e.g., lobectomy, pneumonectomy, thoracotomy, or VATS)
* Hemodynamically stable in the postoperative period
* Cognitively and physically able to perform breathing exercises and use devices (incentive spirometer/HFCWO vest)
* Willing to participate and provide informed consent
Exclusion Criteria:
* Pre-existing severe pulmonary diseases (e.g., COPD, cystic fibrosis, bronchiectasis)
* Contraindications to HFCWO (e.g., recent rib fractures, chest wall trauma, unstable cardiovascular status)
* Cognitive, neuromuscular, or musculoskeletal impairments limiting participation in interventions
* Prolonged mechanical ventilation (\>24 hours postoperatively)
* Active pulmonary infection or hemoptysis within one week after surgery
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Forced Expiratory Volume in 1 second (FEV₁)
Timeframe: Baseline (preoperative), Postoperative Day 3, and Day 5
2
Forced Vital Capacity (FVC)
Timeframe: Baseline (preoperative), Postoperative Day 3, and Day 5
3
Cough Effectiveness
Timeframe: Baseline, Postoperative Day 3, and Day 5